Groundbreaking Fluorescent Detection Technology.
Clear results, in 15 minutes, written in words.
Internal quality control systems protect against incorrect sampling.
Available for sale in the U.S. only.
How it works
The test includes a nasal swab with protect child adapter, a dropper, processing fluid, and a Bluetooth® connected analyzer for use with an app on your phone.
The app will guide you through the test including an integrated information video and step-by-step instructions. The sample is analyzed and the result is displayed on your phone after 15 minutes. Results are saved within the app and can be shared via email.
The Ellume COVID-19 Home Test complies with CDC reporting requirements and automatically reports the required data to health authorities through our secure encrypted, HIPAA compliant, cloud connection.
Features and benefits
- Groundbreaking Fluorescent Detection Technology previously limited to healthcare professionals
- Clear results written in words, no faint lines to interpret
- Results in 15 minutes
- 96% accurate one of the highest accuracy ratings among rapid antigen home tests
- Suitable for ages 2 years and above
- Patented, user-friendly nasal swab with child adapter
- Designed and extensively tested for personal use
- Step-by-step instructions in the app
- Ground breaking, patented fluorescent detection technology
- Ideal for travel and event testing
- Internal quality control systems protect against incorrect sampling
Coronavirus: The Facts
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. COVID-19 is a respiratory illness primarily spread from person to person. COVID-19 symptoms can range from mild (or no symptoms) to severe illness. While multiple vaccines for COVID-19 are now authorized, rapid diagnosis remains pivotal to minimizing transmission.
In the USA, this product has not been FDA cleared or approved; but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C.360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.